Dashboard
Manage Tickers

KIDS ORTHOPEDIATRICS CORP

Nasdaq orthopediatrics.com


$ 16.32 $ -0.08 (-0.49 %)    

Thursday, 06-Nov-2025 12:51:55 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 613.95 $ -7.81 (-1.26 %)
DIA $ 469.06 $ -2.97 (-0.63 %)
SPY $ 671.39 $ -5.08 (-0.75 %)
TLT $ 89.68 $ 0.13 (0.15 %)
GLD $ 366.65 $ -0.52 (-0.14 %)
$ 16.37
$ 16.07
$ 16.30 x 209
$ 16.33 x 80
$ 16.07 - $ 16.18
$ 15.28 - $ 32.00
161,899
na
410.52M
$ 1.05
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-29-2025 09-30-2025 10-Q
2 08-06-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 03-05-2025 01-01-1970 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-06-2024 06-30-2024 10-Q
7 05-07-2024 03-31-2024 10-Q
8 03-08-2024 12-31-2023 10-K
9 11-07-2023 09-30-2023 10-Q
10 08-01-2023 06-30-2023 10-Q
11 05-02-2023 03-31-2023 10-Q
12 03-01-2023 12-31-2022 10-K
13 11-01-2022 09-30-2022 10-Q
14 08-04-2022 06-30-2022 10-Q
15 05-05-2022 03-31-2022 10-Q
16 03-03-2022 12-31-2021 10-K
17 11-04-2021 09-30-2021 10-Q
18 08-05-2021 06-30-2021 10-Q
19 05-06-2021 03-31-2021 10-Q
20 03-11-2021 12-31-2020 10-K
21 11-05-2020 09-30-2020 10-Q
22 08-06-2020 06-30-2020 10-Q
23 05-06-2020 03-31-2020 10-Q
24 03-05-2020 12-31-2019 10-K
25 11-08-2019 09-30-2019 10-Q
26 08-13-2019 06-30-2019 10-Q
27 05-09-2019 03-31-2019 10-Q
28 03-07-2019 12-31-2018 10-K
29 10-31-2018 09-30-2018 10-Q
30 08-09-2018 06-30-2018 10-Q
31 05-15-2018 03-31-2018 10-Q
32 03-15-2018 12-31-2017 10-K
33 11-13-2017 09-30-2017 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

demystifying-orthopediatrics-insights-from-9-analyst-reviews
Demystifying OrthoPediatrics: Insights Fro...
10/29/2025 11:45:12

needham-maintains-buy-on-orthopediatrics-lowers-price-target-to-26
Needham Maintains Buy on OrthoPediatrics, ...
10/29/2025 10:20:51

Needham analyst Mike Matson maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and lowers the price target from $42 to $26.

btig-reiterates-buy-on-orthopediatrics-maintains-23-price-target
BTIG Reiterates Buy on OrthoPediatrics, Ma...
10/29/2025 09:26:38

BTIG analyst Ryan Zimmerman reiterates OrthoPediatrics (NASDAQ:KIDS) with a Buy and maintains $23 price target.

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
10/28/2025 21:13:44

orthopediatrics-affirms-fy2025-sales-guidance-of-233500m-234500m-vs-235476m-est
OrthoPediatrics Affirms FY2025 Sales Guida...
10/28/2025 20:08:40

OrthoPediatrics (NASDAQ:KIDS) affirms FY2025 sales outlook from $233.500 million-$234.500 million to $233.500 million-$234.500 ...

orthopediatrics-q3-adj-eps-024-beats-026-estimate-sales-61250m-miss-62410m-estimate
OrthoPediatrics Q3 Adj. EPS $(0.24) Beats ...
10/28/2025 20:07:19

OrthoPediatrics (NASDAQ:KIDS) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.2...

orthopediatrics-gets-fdas-approval-for-3p-pediatric-plating-platform-small-mini-system
OrthoPediatrics Gets FDA's Approval For 3P...
10/28/2025 20:05:21

OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (Nasdaq: KIDS), a company focused exclusively on adv...

earnings-scheduled-for-october-28-2025
Earnings Scheduled For October 28, 2025
10/28/2025 11:11:34

lake-street-maintains-buy-on-orthopediatrics-lowers-price-target-to-34
Lake Street Maintains Buy on OrthoPediatri...
10/10/2025 17:17:08

Lake Street analyst Ben Haynor maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and lowers the price target from $37 to $34.

stifel-maintains-buy-on-orthopediatrics-lowers-price-target-to-20
Stifel Maintains Buy on OrthoPediatrics, L...
10/10/2025 13:49:40

Stifel analyst Rick Wise maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and lowers the price target from $32 to $20.

jmp-securities-maintains-market-outperform-on-orthopediatrics-lowers-price-target-to-25
JMP Securities Maintains Market Outperform...
10/10/2025 12:59:56

JMP Securities analyst David Turkaly maintains OrthoPediatrics (NASDAQ:KIDS) with a Market Outperform and lowers the price t...

piper-sandler-maintains-overweight-on-orthopediatrics-lowers-price-target-to-22
Piper Sandler Maintains Overweight on Orth...
10/10/2025 12:35:13

Piper Sandler analyst Matt O'Brien maintains OrthoPediatrics (NASDAQ:KIDS) with a Overweight and lowers the price target...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
10/10/2025 12:07:59

nurix-therapeutics-posts-downbeat-q3-results-joins-orthopediatrics-levi-strauss-and-other-big-stocks-moving-lower-in-fridays-pre-market-session
Nurix Therapeutics Posts Downbeat Q3 Resul...
10/10/2025 12:02:09

btig-maintains-buy-on-orthopediatrics-lowers-price-target-to-23
BTIG Maintains Buy on OrthoPediatrics, Low...
10/10/2025 10:24:30

BTIG analyst Ryan Zimmerman maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and lowers the price target from $39 to $23.

why-applied-digital-shares-are-trading-higher-by-around-25-here-are-20-stocks-moving-premarket
Why Applied Digital Shares Are Trading Hig...
10/10/2025 09:06:13

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/09/2025 21:06:16

orthopediatrics-lowers-fy2025-sales-guidance-from-237000m-242000m-to-233500m-234500m-vs-239440m-est
OrthoPediatrics Lowers FY2025 Sales Guidan...
10/09/2025 20:53:39

OrthoPediatrics (NASDAQ:KIDS) lowers FY2025 sales outlook from $237.000 million-$242.000 million to $233.500 million-$234.500 m...

orthopediatrics-sees-q3-sales-61200m-vs-63590m-est
OrthoPediatrics Sees Q3 Sales $61.200M vs ...
10/09/2025 20:53:22

OrthoPediatrics (NASDAQ:KIDS) sees Q3 sales of $61.200 million vs $63.590 million analyst estimate.

orthopediatrics-says-in-q3-faced-incremental-headwinds-late-in-sept-largely-due-to-delayed-7d-capital-sales-headwinds-within-latin-s-america-segment
OrthoPediatrics Says In Q3, Faced Incremen...
10/09/2025 20:24:23

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION